Urinary Extracellular Vesicle–Associated EphA2 Predicts Intravesical Recurrence in Bladder Cancer
International Journal of Urology · 2026-10 · 33 (10)
DOI: 10.1111/iju.70656 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Urology, online erschienen am 13.10.2026. Verfasst von Mamoru Hashimoto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Biomarkers, Tumor, Urinary Bladder Neoplasms, Receptor, EphA2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To examine the clinical usefulness of EphA2 detected on urinary extracellular vesicles (uEphA2) for bladder cancer detection and for estimating the risk of intravesical recurrence after transurethral resection of bladder tumor (TURBT).
Methods
An enzyme‐linked immunosorbent assay was established to measure EphA2‐positive urinary extracellular vesicles. The diagnostic cohort comprised 191 participants, including 120 patients with bladder cancer and 71 controls. Results uEphA2 concentrations were higher in patients with bladder cancer than in controls. Receiver operating characteristic analysis yielded an area under the curve of 0.679, with 46.7% sensitivity and 87.3% specificity. Among patients evaluable for post‐TURBT recurrence, high uEphA2 levels were associated with shorter intravesical recurrence‐free survival. This association remained significant in multivariable Cox regression analysis after adjustment for the EORTC risk score and age. Conclusions uEphA2 showed modest diagnostic accuracy but high specificity and was independently associated with intravesical recurrence. These results support its potential use as a non‐invasive urinary marker for post‐TURBT risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan.
- Department of Urology, Osaka University Graduate School of Medicine, Osaka, Japan.
- FUJIFILM Wako Pure Chemical Corporation, Hyogo, Japan.
ORCID-Profile: Mamoru Hashimoto, Lan Inoki, Koji Miki, Saizo Fujimoto, Yutaka Yamamoto, Takafumi Minami, Kazutoshi Fujita
Zitieren
APA
Hashimoto, M., Tomiyama, E., Inoki, L., Miki, K., Nakayama, T., Fujimoto, S., Toyoda, S., Kikuchi, T., Ukekawa, R., Yamamoto, Y., Minami, T., Yoshimura, K., Nonomura, N., & Fujita, K. (2026). Urinary Extracellular Vesicle–Associated EphA2 Predicts Intravesical Recurrence in Bladder Cancer. International Journal of Urology, 33(10). https://doi.org/10.1111/iju.70656
Vancouver
Hashimoto M, Tomiyama E, Inoki L, Miki K, Nakayama T, Fujimoto S, et al. Urinary Extracellular Vesicle–Associated EphA2 Predicts Intravesical Recurrence in Bladder Cancer. International Journal of Urology. 2026;33(10). doi:10.1111/iju.70656
BibTeX
@article{Hashimoto2026,
author = {Hashimoto, Mamoru and Tomiyama, Eisuke and Inoki, Lan and Miki, Koji and Nakayama, Takahito and Fujimoto, Saizo and Toyoda, Shingo and Kikuchi, Takashi and Ukekawa, Ryo and Yamamoto, Yutaka and Minami, Takafumi and Yoshimura, Kazuhiro and Nonomura, Norio and Fujita, Kazutoshi},
title = {Urinary Extracellular Vesicle–Associated EphA2 Predicts Intravesical Recurrence in Bladder Cancer},
journal = {International Journal of Urology},
year = {2026},
volume = {33},
number = {10},
doi = {10.1111/iju.70656}
}
EUVIMED